The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
about
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers.Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.Oral anticoagulation therapy upon discharge in hospitalized patients with nonvalvular atrial fibrillation: a retrospective cohort study.Vitamin D and bone health: interpreting observational studies.Dietary Therapy for Eosinophilic Esophagitis: Elimination and Reintroduction.Letter: proton pump inhibitor use and fracture risk.Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response.The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study.Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Whole greater than the parts: integrated esophageal centers (IEC) and advanced training in esophageal diseases.Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Modulation of the oxidative plasmatic state in gastroesophageal reflux disease with the addition of rich water molecular hydrogen: A new biological vision.Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal.Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective.Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease.A Review of Tertiary Referrals for Management of Pediatric Esophageal Eosinophilia.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Proton Pump Inhibitors: Are They a Real Threat to the Patient?Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort studyEndoscopic augmentation of gastroesophageal junction using a full-thickness endoscopic suturing device
P2860
Q38646393-ED89A3D0-7D8C-4B9F-9278-20011A56043CQ38809179-B7F92C22-15A5-4981-A2C4-CC2C64EE7EFAQ42364784-A7C20BBC-E7C5-490D-8385-9002DF0B5905Q42695192-B1CAB9C9-E989-4ADB-8D51-1293B1BA282BQ47336250-758D316E-CB3C-49E8-AC0E-5133F2CBFDF4Q48118420-7B2BFB20-69A7-43D3-A034-A3E020367C5AQ48120786-4D1031CD-25DB-412F-95F0-CE19780A509CQ48288782-6857D27E-2AA6-4418-B638-CCDEE837C87BQ48353820-9ADC4E91-5D96-4B01-9C62-59CDC7964968Q49190282-42683AA2-7F8B-4F32-A7ED-F09EE44CAB0CQ49212128-47FD5241-83D2-4949-85F9-F46FC09E2D75Q49447901-293A4F28-70B7-4286-8D09-4A4C4BB3B739Q49546655-D72D04D7-FD39-4810-8746-1213179256F8Q49988267-86A9D883-CEC3-410D-99D6-FD089597B3E6Q50046112-DC1D5025-A05E-4299-84F5-53AC2622525EQ50129556-1FA77094-05E5-44FE-9243-5B729E8F9097Q50243582-6D6D79BD-EB85-4097-8CC0-E0838CB19BBBQ51411912-8BAD3AEC-A296-48A1-9554-FCF24F10F91AQ51761248-4317A13F-03AE-4DB7-AFA1-297282140574Q51765253-BACB5106-49EB-4AD3-95BB-3AE92B52CA98Q53821829-12B6F06B-DFC9-4C5E-8880-63E748F0845BQ55001719-2B316DBA-DCC0-4B87-A4C0-C0E1ECEB37FEQ55071130-A71776E6-409F-4C59-8E3E-A92970828206Q55113683-3B31D4E2-0D51-45FD-90E4-7DA555C4C08CQ55278241-F7C18040-EBDC-4132-BF46-B25FE05B1C7BQ55403880-70BE5D16-1BE8-4CDF-AECF-DBAF40B439D6Q55493690-1FE166DC-D8C0-4805-84DA-EA46D2E55A60Q57494425-30A4A067-5565-4DA1-A247-50EAA43471BBQ58747747-64862C43-1A8B-4B9F-8263-483B3652E25CQ58752080-2385A187-2B21-4EA1-9E7E-7AE842865280
P2860
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The Risks and Benefits of Long ...... stroenterological Association.
@ast
The Risks and Benefits of Long ...... stroenterological Association.
@en
The Risks and Benefits of Long ...... stroenterological Association.
@nl
type
label
The Risks and Benefits of Long ...... stroenterological Association.
@ast
The Risks and Benefits of Long ...... stroenterological Association.
@en
The Risks and Benefits of Long ...... stroenterological Association.
@nl
prefLabel
The Risks and Benefits of Long ...... stroenterological Association.
@ast
The Risks and Benefits of Long ...... stroenterological Association.
@en
The Risks and Benefits of Long ...... stroenterological Association.
@nl
P2093
P1433
P1476
The Risks and Benefits of Long ...... stroenterological Association.
@en
P2093
Daniel E Freedberg
Lawrence S Kim
Yu-Xiao Yang
P304
P356
10.1053/J.GASTRO.2017.01.031
P407
P577
2017-03-01T00:00:00Z